Meckel-Gruber syndrome (MKS) is a rare lethal autosomal recessive disease that is the most common cause of syndromic neural tube defects. There are five causative genes, mapped to six known disease loci, whose products encode proteins involved in formation and function of primary cilia. One of these genes, MKS3 (located on chromosome 8q22.1), is now well-characterized and a number of mutations in this gene have now been identified in MKS patients, and for the allelic condition Joubert syndrome. MKS3 encodes meckelin, a putative Frizzled-like transmembrane receptor that localizes to the ciliary membrane and apical cell surface in ciliated cells. MKS3 mutation screening of MKS patients has revealed a number of missense, in-frame deletion and synonymous sequence variants of unknown pathogenic potential. To assess the pathogenicity of these variants in functional assays, we determined the subcellular localization of mutated forms of HA epitopetagged meckelin, in comparison to a wild-type construct and endogenous meckelin. We introduced patient mutations using a standard site-directed mutagenesis strategy. Ciliated cells were transiently transfected with these constructs, immunostained with anti-HA and anti-calreticulin (an ER marker) and visualized by confocal microscopy. This revealed diverse meckelin localizations, which differ from the wild-type and endogenous, including aberrant ER aggregation. Our results demonstrate that mislocalization of meckelin is the probable pathogenic mechanism for a number of mutations in MKS.
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On-going work is assessing the consequences of these mutations on non-canonical Wnt signaling. 
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Isolation of NOCE, a novel node and notochord-specific enhancer element from the Noto locus Leonie Alten, Karin Schuster-Gossler, Anja Beckers,
Achim Gossler
Medical School Hannover, Hannover, Germany Noto encodes a homeobox transcription factor that is expressed in the node and nascent notochord [Abdelkhalek et al., 2004] . Loss of Noto disrupts ciliogenesis in the embryonic node and node morphology [Beckers et al., 2007] . To further investigate the mechanisms that regulate ciliogenesis and node morphology, Noto is being analysed with respect to its regulation, as well as downstream effectors.
To identify relevant regulatory sequences we used single copy insertions of promoter-reporter constructs into ES cells [Bronson et al., 1996] and analysed these in chimeric embryos. This analysis led to the localisation of the novel enhancer region NOCE (node and notochord-specific enhancer) that is necessary and sufficient to resemble the expression of endogenous Noto. NOCE is 500 bp long and contains the previously non-described regulatory sequence UFO (unknown factor binding site) that is necessary for its function. The ongoing analysis of NOCE and UFO should help to identify new upstream factors regulating node and notochordspecific gene expression. The ENU-derived, embryonic lethal mouse mutant Gasping 6 (gpg6) demonstrates exencephaly, oedema, coloboma, pulmonary hypoplasia and aplasia and left-right patterning defects in heart and lungs, indicative of defective hedgehog (hh) signalling. We show that gpg6 contains cilia associated defects, and explain how these underlie both the hh and left-right defects; gpg6 has abnormally short cilia, negatively regulates the hh pathway and disrupts expression of Nodal, a key determinant of left-right patterning.
We have found a mutation in gpg6 within the transcription factor Atmin. We propose a hypothesis explaining how this muta- RNAi screen was conducted for ciliary genes that can disrupt Shh signaling. We identified a novel gene, B9D1, which is required for S269
